Drug–drug Interaction between Pravastatin and Gemfibrozil (Antihyperlipidemic) with Gliclazide (Antidiabetic) in Rats
2010

Drug Interaction Study of Gliclazide with Pravastatin and Gemfibrozil in Rats

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): Sultanpur CM, Satyanarayana S, Reddy NS, Kumar KE, Kumar S

Primary Institution: Government College of Pharmacy, Bangalore, India

Hypothesis

The study aims to evaluate the safety of gliclazide in the presence of pravastatin and gemfibrozil in rats.

Conclusion

The combination of gliclazide with pravastatin and gemfibrozil enhances the hypoglycemic effect and should be used with caution.

Supporting Evidence

  • Gliclazide produced a maximum reduction of blood glucose levels at 2 and 8 hours.
  • The combination treatment increased the hypoglycemic effect of gliclazide in both normal and diabetic rats.
  • Pravastatin and gemfibrozil inhibit the metabolism of gliclazide, leading to enhanced effects.

Takeaway

This study looked at how a diabetes medicine works with two cholesterol medicines in rats, finding that they can make the diabetes medicine work better.

Methodology

The study involved administering gliclazide alone and in combination with pravastatin and gemfibrozil to normal and diabetic rats, followed by blood glucose analysis.

Limitations

The study was conducted only in rats, and results may not directly translate to humans.

Participant Demographics

Albino rats of either sex, weighing between 160 and 280 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.4103/0975-1483.63157

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication